Orion Financial Statements From 2010 to 2024
| ORINFDelisted Stock | USD 38.38 0.00 0.00% |
Check Orion Oyj financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orion Oyj's main balance sheet or income statement drivers, such as , as well as many indicators such as . Orion financial statements analysis is a perfect complement when working with Orion Oyj Valuation or Volatility modules.
Orion |
Orion Oyj Company Return On Equity Analysis
Orion Oyj's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Orion Oyj Return On Equity | 0.41 |
Most of Orion Oyj's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orion Oyj is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Orion Oyj has a Return On Equity of 0.4065. This is 101.7% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The return on equity for all United States stocks is notably lower than that of the firm.
Orion Oyj Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Orion Oyj's current stock value. Our valuation model uses many indicators to compare Orion Oyj value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orion Oyj competition to find correlations between indicators driving Orion Oyj's intrinsic value. More Info.Orion Oyj is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Orion Oyj is roughly 1.96 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orion Oyj's earnings, one of the primary drivers of an investment's value.About Orion Oyj Financial Statements
Orion Oyj stakeholders use historical fundamental indicators, such as Orion Oyj's revenue or net income, to determine how well the company is positioned to perform in the future. Although Orion Oyj investors may analyze each financial statement separately, they are all interrelated. For example, changes in Orion Oyj's assets and liabilities are reflected in the revenues and expenses on Orion Oyj's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Orion Oyj. Please read more on our technical analysis and fundamental analysis pages.
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients in Finland, Scandinavia, other European countries, North America, and internationally. Orion Oyj has partnership with Propeller Health to connect the Easyhaler line of inhalers for asthma and COPD to Propellers digital medicine platform and a research collaboration and license agreement with Alligator Bioscience AB to discover and develop new bispecific antibody cancer therapeutics. Orion Corp is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Orion Pink Sheet
If you are still planning to invest in Orion Oyj check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orion Oyj's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |